Annual Retained Earnings
-$743.01 M
-$198.71 M-36.51%
December 31, 2024
Summary
- As of March 6, 2025, VERV annual retained earnings is -$743.01 million, with the most recent change of -$198.71 million (-36.51%) on December 31, 2024.
- During the last 3 years, VERV annual retained earnings has fallen by -$556.16 million (-297.65%).
- VERV annual retained earnings is now -3466.70% below its all-time high of -$20.83 million, reached on December 31, 2019.
Performance
VERV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$743.01 M
-$50.03 M-7.22%
December 1, 2024
Summary
- As of March 6, 2025, VERV quarterly retained earnings is -$743.01 million, with the most recent change of -$50.03 million (-7.22%) on December 1, 2024.
- Over the past year, VERV quarterly retained earnings has stayed the same.
- VERV quarterly retained earnings is now -1016.71% below its all-time high of -$66.54 million, reached on December 1, 2020.
Performance
VERV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VERV Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.5% | 0.0% |
| 3 y3 years | -297.6% | -49.8% |
| 5 y5 years | -3466.7% | -49.8% |
VERV Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -297.6% | at low | -297.6% | at low |
| 5 y | 5-year | -3466.7% | at low | -1016.7% | at low |
| alltime | all time | -3466.7% | at low | -1016.7% | at low |
Verve Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$743.01 M(+36.5%) | - |
| Dec 2024 | - | -$743.01 M(+7.2%) |
| Sep 2024 | - | -$692.98 M(+7.8%) |
| Jun 2024 | - | -$642.85 M(+8.4%) |
| Mar 2024 | - | -$593.04 M(+9.0%) |
| Dec 2023 | -$544.30 M(+58.1%) | -$544.30 M(+9.7%) |
| Sep 2023 | - | -$495.95 M(+10.2%) |
| Jun 2023 | - | -$450.19 M(+13.6%) |
| Mar 2023 | - | -$396.21 M(+15.1%) |
| Dec 2022 | -$344.24 M | -$344.24 M(+13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$303.15 M(+17.5%) |
| Jun 2022 | - | -$257.96 M(+18.9%) |
| Mar 2022 | - | -$217.02 M(+16.1%) |
| Dec 2021 | -$186.85 M(+180.8%) | -$186.85 M(+20.2%) |
| Sep 2021 | - | -$155.51 M(+17.1%) |
| Jun 2021 | - | -$132.76 M(+66.4%) |
| Mar 2021 | - | -$79.80 M(+19.9%) |
| Dec 2020 | -$66.54 M(+219.4%) | - |
| Dec 2020 | - | -$66.54 M |
| Dec 2019 | -$20.83 M | - |
FAQ
- What is Verve Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Verve Therapeutics?
- What is Verve Therapeutics annual retained earnings year-on-year change?
- What is Verve Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Verve Therapeutics?
- What is Verve Therapeutics quarterly retained earnings year-on-year change?
What is Verve Therapeutics annual retained earnings?
The current annual retained earnings of VERV is -$743.01 M
What is the all time high annual retained earnings for Verve Therapeutics?
Verve Therapeutics all-time high annual retained earnings is -$20.83 M
What is Verve Therapeutics annual retained earnings year-on-year change?
Over the past year, VERV annual retained earnings has changed by -$198.71 M (-36.51%)
What is Verve Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VERV is -$743.01 M
What is the all time high quarterly retained earnings for Verve Therapeutics?
Verve Therapeutics all-time high quarterly retained earnings is -$66.54 M
What is Verve Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VERV quarterly retained earnings has changed by $0.00 (0.00%)